Merlin Capital LLC Amyris, Inc. Transaction History

Merlin Capital LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	BUY	$0.58 - $1.3 $143,163 - $320,884	246,834 New	246,834 $457,000
Q4 2022 Feb 13, 2023	BUY	$1.52 - $3.39 $625,957 - $1.4 Million	411,814 Added 196.52%	621,369 $950,000
Q3 2022 Nov 14, 2022	SELL	$1.7 - $4.05 $63,374 - $150,979	-37,279 Reduced 15.1%	209,555 $612,000
Q2 2022 Jul 20, 2022	SELL	$1.6 - $5.07 $161,267 - $511,015	-100,792 Reduced 28.99%	246,834 $457,000
Q1 2022 May 16, 2022	BUY	$3.92 - $5.86 $184,581 - $275,929	47,087 Added 15.67%	347,626 $1.52 Million
Q4 2021 Mar 14, 2022	BUY	$5.0 - $14.85 $1.5 Million - $4.46 Million	300,539 New	300,539 $1.63 Million

230K

Ticker AMRS
Exchange NASDAQ
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 324,860,000
Market Cap $3.25M
Description
Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty, and flavors and fragrance markets in Europe, North America, Asia, and South America. The company manufactures and sells clean beauty, personal care, and health and wellness consumer products, as well as ingredients to the flavor and fragrance, nutrition, fo...

Get notified when there are updates to the investment portfolio of Merlin Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Merlin Capital LLC with notifications on news.